United States · FDA National Drug Code directory
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13107-069_44a9eb77-0896-4b62-9953-7121d97d6ffd
- Product NDC
- 13107-069
- Form
- TABLET
- Composition / generic term
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
- Labeler
- Aurolife Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20131127
- Source listing expiry
- 20271231
Source-listed ingredients
- DEXTROAMPHETAMINE SACCHARATE — 1.875 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE — 1.875 mg/1
- DEXTROAMPHETAMINE SULFATE — 1.875 mg/1
- AMPHETAMINE SULFATE — 1.875 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (13107-069-01) · 13107-069-01
- 500 TABLET in 1 BOTTLE (13107-069-05) · 13107-069-05
- 250 TABLET in 1 BOTTLE (13107-069-25) · 13107-069-25
- 50 TABLET in 1 BOTTLE (13107-069-50) · 13107-069-50
- 1000 TABLET in 1 BOTTLE (13107-069-99) · 13107-069-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →